AMRN Amarin Corp Plc
Price (delayed)
$0.5891
Market cap
$242.32M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.1
Enterprise value
$93.06M
Amarin is a rapidly growing, innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. From its scientific research foundation to its focus on clinical trials, and now its
Highlights
AMRN's quick ratio is up by 25% year-on-year and by 11% since the previous quarter
AMRN's debt is down by 8% year-on-year
AMRN's net income is up by 25% YoY but it is down by 17% from the previous quarter
The company's EPS rose by 17% YoY but it fell by 11% QoQ
Amarin's gross profit has decreased by 26% YoY and by 9% QoQ
The revenue is down by 25% year-on-year and by 9% since the previous quarter
Key stats
What are the main financial stats of AMRN
Market
Valuations
Earnings
Shares outstanding
411.34M
Market cap
$242.32M
Enterprise value
$93.06M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.46
Price to sales (P/S)
1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.39
Revenue
$241.02M
Gross profit
$136.07M
Operating income
-$44.11M
Net income
-$39.35M
EBIT
-$31.32M
EBITDA
-$28.31M
Free cash flow
-$18.86M
Per share
Balance sheet
Liquidity
EPS
-$0.1
EPS diluted
-$0.1
Free cash flow per share
-$0.05
Book value per share
$1.29
Revenue per share
$0.59
TBVPS
$1.78
Total assets
$750.62M
Total liabilities
$219.24M
Debt
$8.22M
Equity
$531.38M
Working capital
$448.66M
Debt to equity
0.02
Current ratio
3.23
Quick ratio
2.08
Net debt/EBITDA
5.27
Margins
Efficiency
Dividend
EBITDA margin
-11.7%
Gross margin
56.5%
Net margin
-16.3%
Operating margin
-18.3%
Return on assets
-5%
Return on equity
-7.2%
Return on invested capital
-8.8%
Return on capital employed
-5.7%
Return on sales
-13%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AMRN stock price
How has the Amarin stock price performed over time
Intraday
-0.82%
1 week
-3.8%
1 month
3.42%
1 year
-49.65%
YTD
21.46%
QTD
21.46%
Financial performance
How have Amarin's revenue and profit performed over time
Revenue
$241.02M
Gross profit
$136.07M
Operating income
-$44.11M
Net income
-$39.35M
Gross margin
56.5%
Net margin
-16.3%
AMRN's operating income is up by 39% year-on-year but it is down by 9% since the previous quarter
AMRN's net margin is down by 28% since the previous quarter
Amarin's gross profit has decreased by 26% YoY and by 9% QoQ
The revenue is down by 25% year-on-year and by 9% since the previous quarter
Growth
What is Amarin's growth rate over time
Valuation
What is Amarin stock price valuation
P/E
N/A
P/B
0.46
P/S
1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.39
The company's EPS rose by 17% YoY but it fell by 11% QoQ
AMRN's P/B is 74% below its 5-year quarterly average of 1.8 and 23% below its last 4 quarters average of 0.6
The equity has declined by 3.9% year-on-year and by 3.7% since the previous quarter
The P/S is 55% less than the 5-year quarterly average of 2.2 and 17% less than the last 4 quarters average of 1.2
The revenue is down by 25% year-on-year and by 9% since the previous quarter
Efficiency
How efficient is Amarin business performance
The ROIC has soared by 51% YoY but it has decreased by 3.5% QoQ
The company's return on sales rose by 36% YoY but it fell by 21% QoQ
Amarin's ROA has decreased by 22% from the previous quarter but it has increased by 18% YoY
AMRN's ROE is up by 21% YoY but it is down by 18% from the previous quarter
Dividends
What is AMRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AMRN.
Financial health
How did Amarin financials performed over time
AMRN's quick ratio is up by 25% year-on-year and by 11% since the previous quarter
AMRN's total liabilities is down by 23% year-on-year and by 12% since the previous quarter
AMRN's debt is 98% smaller than its equity
Amarin's debt to equity has soared by 100% from the previous quarter
AMRN's debt is down by 8% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.